BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3885020)

  • 1. Desmutagenic effects of N-acetylcysteine on direct and indirect mutagens.
    Wilpart M; Mainguet P; Geeroms D; Roberfroid M
    Mutat Res; 1985 Apr; 142(4):169-77. PubMed ID: 3885020
    [No Abstract]   [Full Text] [Related]  

  • 2. Acrylamide as an inducer of metabolic activation system (S9) in rats.
    el-Din AY; al-Maskati HA; Mohamed AY; Dairi MG
    Mutat Res; 1993 Jul; 300(2):91-7. PubMed ID: 7685498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity and anti-mutagenicity of selected spices.
    Soudamini KK; Unnikrishnan MC; Sukumaran K; Kuttan R
    Indian J Physiol Pharmacol; 1995 Oct; 39(4):347-53. PubMed ID: 8582746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Todralazine influence upon the mutagenicity of some direct- and indirect-acting mutagens.
    Gasiorowski K; Szyba K; Urban J
    Mutat Res; 1994 Jul; 324(3):133-7. PubMed ID: 7517512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of aromatic amines to mutagens by various animal species including man.
    Phillipson CE; Ioannides C
    Mutat Res; 1983 Dec; 124(3-4):325-36. PubMed ID: 6361543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the relationship of metabolic activation system concentrations and chemical dose concentrations for the Salmonella spiral and plate assays.
    Claxton LD; Houk VS; Allison JC; Creason J
    Mutat Res; 1991 Oct; 253(2):127-36. PubMed ID: 1922139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of pine cone extract fraction VI with mutagens.
    Lee H; Aoki K; Sakagami H; Yoshida T; Kuroiwa Y
    Mutat Res; 1993 Jul; 297(1):53-60. PubMed ID: 7686273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens.
    Saito J; Sakai Y; Nagase H
    Mutat Res; 2006 Oct; 609(1):68-73. PubMed ID: 16884943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
    Jacobs MM; Matney TS; Griffin AC
    Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of mutagens in aqueous fecal extracts with a modified ames Salmonella test.
    Shaw R; Andrews AW; Riggs CW
    Teratog Carcinog Mutagen; 1985; 5(1):15-27. PubMed ID: 2859658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aminothiols in 2-acetylaminofluorene-treated rats. III. Metabolic activation of aromatic amines.
    De Flora S; Camoirano A; Bennicelli C; Orunesu M; Cesarone CF
    In Vivo; 1987; 1(2):101-7. PubMed ID: 2979769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of secondary biliary acids on the mutagenicity of N-methyl-N'-nitro-N-nitrosoguanidine, 2-acetylaminofluorene and 2-nitrofluorene towards Salmonella typhimurium strains.
    Wilpart M; Roberfroid M
    Carcinogenesis; 1986 May; 7(5):703-6. PubMed ID: 3516434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Haug LT; Dybing E
    Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinol (vitamin A) as a modifier of 2-aminofluorene and 2-acetyl-aminofluorene mutagenesis in the Salmonella/microsome assay.
    Busk L; Ahlborg UG
    Arch Toxicol; 1982 Jan; 49(2):169-74. PubMed ID: 7036954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent activation of 2-acetylaminofluorene and some aromatic amines by cytosolic preparations.
    Forster R; Green MH; Priestley A; Gorrod JW
    Mutat Res; 1981 Aug; 85(4):187-94. PubMed ID: 7022188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of covalent DNA binding and mutagenicity of benzo[a]pyrene by isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl) carbamoyl]acetate (YH439), a novel hepatoprotective agent.
    Surh YJ; Shlyankevich M; Lee JW; Yoo JK
    Mutat Res; 1996 Apr; 367(4):219-24. PubMed ID: 8628328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA; Shane BS; Hajos AK; Winston GW
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of metabolic activation of the promutagens, benzo[a]pyrene, 2-aminofluorene and 2-aminoanthracene by furanochromones in Salmonella typhimurium.
    Schimmer O; Rauch P
    Mutagenesis; 1998 Jul; 13(4):385-9. PubMed ID: 9717176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic formation of pyrenequinones as enhancing agents of mutagenicity in Salmonella.
    Okamoto H; Yoshida D
    Cancer Lett; 1981 Jan; 11(3):215-20. PubMed ID: 7018664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prostaglandin H synthase-dependent activation of 2-aminofluorene to products mutagenic to S. typhimurium strains TA98 and TA98NR.
    Boyd JA; Zeiger E; Eling TE
    Mutat Res; 1985 Jul; 143(3):187-90. PubMed ID: 3925332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.